Educational only — not medical advice. If you’re in crisis or thinking about suicide: call or text 988 (U.S.) or your local emergency number. Support resources. Under construction and review—see the updates log.
Brand: VALIUM
Published 2026-02-13 · Last reviewed 2026-02-20 · 4 references
Content sourced from FDA labeling (DailyMed) and peer-reviewed literature.
Diazepam is a long-acting benzodiazepine used for anxiety, alcohol withdrawal, muscle spasm, and seizure-related indications (label varies by product). In psychiatric practice it may be used as a short-term bridge for severe anxiety or agitation when rapid relief is required.
Long half-life and active metabolites can provide smoother coverage but also increase accumulation, next-day impairment, and fall risk—key concerns in older adults and in serious mental illness with polypharmacy.
Because of its long duration, diazepam is sometimes used as part of a structured taper strategy from shorter-acting benzodiazepines, but it still carries substantial misuse and overdose risk; short courses with explicit goals and a stop plan are common.
Generally avoided or used with extreme caution in older adults, significant liver disease, untreated sleep apnea/COPD, and with concurrent opioids or alcohol; the safety risks of carryover sedation and falls can outweigh any benefit.
The diazepam compare view, diazepam evidence feed, and diazepam print page can support safe-use counseling and shared decision-making when aligning short-term calming strategies with safety planning.
Often reserved for targeted, time-limited indications with explicit taper plans and frequent reassessment; open-ended chronic use is generally avoided. Long half-life and active metabolites can smooth coverage but also increase carryover impairment, especially in older adults and with polypharmacy—prescriptions are typically short with a defined stop date and reassessment at renewals.
View labelExactRefer to the Glossary entry on Neurotransmitters for background on receptor systems involved in serious mental illness.
Positive allosteric modulator of GABA-A receptors that increases inhibitory neurotransmission.
Produces anxiolysis, sedation, and anticonvulsant effects; long half-life increases carryover impairment risk.
Diazepam treats symptoms but does not address underlying anxiety drivers; it is often paired with psychotherapy and SSRI/SNRI-based plans when ongoing anxiety is present.
Sources: FDA/DailyMed label; guideline statements.